Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.

Leung YH, Lim WL, Wong MH, Chuang SK.

Epidemiol Infect. 2012 May;140(5):814-7. doi: 10.1017/S0950268811001415. Epub 2011 Jul 29.

PMID:
21801465
2.

Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.

Na S, Chong YP, Kim MN, Kim WY, Kim W, Hong SB, Lim CM, Koh Y, Kwon JW, Hong SJ, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH.

J Med Virol. 2011 Jan;83(1):5-9. doi: 10.1002/jmv.21935.

PMID:
21108333
3.

Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.

Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS.

Clin Infect Dis. 2010 Apr 1;50(7):963-9. doi: 10.1086/651083.

PMID:
20180701
4.

Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.

Kanchana S, Kanchana S, Chuntrakul C, Malathum K, Prachayangprecha S, Poovorawan Y.

J Infect. 2011 Oct;63(4):295-9. doi: 10.1016/j.jinf.2011.08.005. Epub 2011 Aug 9.

PMID:
21840339
5.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.

N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612. Epub 2009 Dec 9.

6.

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6. Epub 2013 Nov 22.

PMID:
24268590
7.

Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.

Gandhoke I, Rawat DS, Rai A, Khare S, Ichhpujani RL.

Indian J Med Microbiol. 2011 Jan-Mar;29(1):37-41. doi: 10.4103/0255-0857.76522.

8.

Viral load in patients infected with pandemic H1N1 2009 influenza A virus.

To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, Hung IF, Lai ST, Leung CW, Kwan YW, Lau YL, Ng TK, Cheng VC, Peiris JS, Yuen KY.

J Med Virol. 2010 Jan;82(1):1-7. doi: 10.1002/jmv.21664.

PMID:
19950247
9.

Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children.

Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, Lin YJ, Kuo HC, Lee IK, Liu JW, Huang EY, Yang KD.

Emerg Infect Dis. 2010 Aug;16(8):1265-72. doi: 10.3201/eid1608.091918.

10.

Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.

Petersen E, Keld DB, Ellermann-Eriksen S, Gubbels S, Ilkjær S, Jensen-Fangel S, Lindskov C.

Scand J Infect Dis. 2011 Jul;43(6-7):495-503. doi: 10.3109/00365548.2011.556144. Epub 2011 Feb 10.

PMID:
21309638
11.

Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009.

Bhattarai A, Villanueva J, Palekar RS, Fagan R, Sessions W, Winter J, Berman L, Lute J, Leap R, Marchbanks T, Sodha SV, Moll M, Xu X, Fry A, Fiore A, Ostroff S, Swerdlow DL; Pennsylvania Working Group.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S102-8. doi: 10.1093/cid/ciq026.

PMID:
21342880
12.

Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.

Malato L, Llavador V, Marmier E, Youssef J, Balick Weber C, Rozé H, Bessede E, Fleury HJ.

Euro Surveill. 2011 Jan 27;16(4). pii: 19776.

13.

Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.

Escuret V, Cornu C, Boutitie F, Enouf V, Mosnier A, Bouscambert-Duchamp M, Gaillard S, Duval X, Blanchon T, Leport C, Gueyffier F, Van Der Werf S, Lina B.

Antiviral Res. 2012 Nov;96(2):130-7. doi: 10.1016/j.antiviral.2012.08.002. Epub 2012 Aug 14.

PMID:
22909899
14.

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.

Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W.

BMJ. 2010 Sep 28;341:c4779. doi: 10.1136/bmj.c4779.

15.

Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.

Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, Alfaro Ramos L, Guevara Gutiérrez R, Manjarrez Zavala ME, Takasaki J, Izumi S, Bautista E, Perez Padilla JR.

PLoS One. 2011;6(7):e21838. doi: 10.1371/journal.pone.0021838. Epub 2011 Jul 8.

16.

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.

Ryoo SM, Kim WY, Sohn CH, Seo DW, Oh BJ, Lee JH, Lee YS, Lim KS.

Influenza Other Respir Viruses. 2013 Sep;7(5):833-7. doi: 10.1111/irv.12065. Epub 2012 Dec 26.

17.

Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR.

Mehta T, McGrath E, Bheemreddy S, Salimnia H, Abdel-Haq N, Ang JY, Lum L, Chandrasekar P, Alangaden GJ.

J Clin Microbiol. 2010 Nov;48(11):4326-8. doi: 10.1128/JCM.01190-10. Epub 2010 Sep 15.

18.

Pandemic (H1N1) 2009 virus infection: prolonged viral shedding and the role of corticosteroids.

Rapose A.

J Infect. 2012 Sep;65(3):281-2; author reply 282. doi: 10.1016/j.jinf.2012.04.013. Epub 2012 May 2. No abstract available.

PMID:
22561090
19.

Risk factors for prolonged shedding of 2009 H1N1 influenza virus.

Chen Y, Qiao H, Zhang CM, Tong M, Shang S.

Indian Pediatr. 2011 Dec;48(12):961-3. Epub 2011 May 30.

20.

[The significance of different sample types in study of pandemic A (H1N1) influenza diagnosis].

Huang F, Shi WX, Lu GL, Cui SJ, Lü YN, Tian LL, Qian HK, Yang P, Wang QY, Pang XH.

Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Dec;44(12):1079-82. Chinese.

PMID:
21215107

Supplemental Content

Support Center